Publication date: Available online 30 October 2026 Source: Annals of the Rheumatic Diseases Author(s): Sabine A Eming, Alexander Kreuter, Matthias Hahn, Kamran Ghoreschi, Pia Moinzadeh, Nicolas Hunzelmann, Kerstin Becker, Nils Reiche, Anne Adams, Kija Shah-Hosseini, Martin Hellmich, Sebastian Willenborg, David E Sanin, Martin Röcken, Thomas Krieg
Interleukin 4-receptor-α blockade in localised scleroderma: a phase 2 proof-of-concept study. // Annals of the Rheumatic Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S0003496726006059?dgcid=rss_sd_all
Interleukin 4-receptor-α blockade in localised scleroderma: a phase 2 proof-of-concept study. Annals of the Rheumatic Diseases. https://www.sciencedirect.com/science/article/pii/S0003496726006059?dgcid=rss_sd_all
“Interleukin 4-receptor-α blockade in localised scleroderma: a phase 2 proof-of-concept study.” Annals of the Rheumatic Diseases.
@article{article36065,
title = {Interleukin 4-receptor-α blockade in localised scleroderma: a phase 2 proof-of-concept study},
journal = {Annals of the Rheumatic Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S0003496726006059?dgcid=rss_sd_all}
}